Most Viewed Articles - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Most Viewed Articles

FDA Specifies DUNS for Drug Facility Registration

November 5, 2014

FDA releases guidance specifying its preferred unique facility identifier system.

Roche Announces 450 Million Swiss Franc Investment on New Facility

November 5, 2014

Roche announced it will spend 450 million Swiss Francs on a new manufacturing facility in Suzhou, China.

M&A Activity in Pharma Still Strong Despite New Tax Rules

November 4, 2014

M&A transactions accounted for nearly $15 billion more this year than for the same period a year ago.

Novartis Sells Influenza Vaccine Business to CSL for $275 Million

October 27, 2014

The divestment will create the number two player in the global influenza vaccine industry.

AbbVie/Shire Deal Officially Off

October 20, 2014

AbbVie to pay Shire $1.635 billion break fee for terminating purchase agreement.

ISPE Releases its Drug Shortages Prevention Plan

October 15, 2014

The International Society for Pharmaceutical Engineering (ISPE) released its Drug Shortages Prevention Plan as part of an initiative to address drug shortage prevention due to manufacturing and quality issues.

AbbVie Reconsiders Shire Offer

October 15, 2014

AbbVie sends Shire notice that it is reconsidering its offer recommendation.

Change is Afoot at CPhI

October 8, 2014

New investments, expansions, and company rebranding are discussed at CPhI.

Meet this year's CPhI Pharma Awards Winners

October 7, 2014

Celebrating the best of pharma and recognizing companies that turn inspiration into innovation.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
23%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
7%
All of the above.
47%
No government involvement in patient treatment or drug development.
9%
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
Click here